The Investigation and DEtection of urological Neoplasia in paTIents reFerred with suspected urinary tract cancer: A multicentre analYsis (IDENTIFY)
IDENTIFY Meeting @ EAU 2018 meeting, Copenhagen: Saturday 17th March 2018 13:00 -14:00 (CET, UTC +1) Meeting Room 14 in the Orange Area
Interest has been unprecedented: over 140 centres across 6 continents have registered, which emphasises the importance of this project. IDENTIFY study deadline extended to at least June 2018. Still plenty of time to recruit patients.
Service Evaluation Project
Clinical practice varies considerably across hospitals and countries for the investigation of patients referred with suspected urinary tract cancer. In the UK, NICE recently set new recommended criteria for suspected cancer referral from primary to secondary care. Furthermore many hospitals have a one-stop clinic where all appropriate investigations may be performed in one visit to screen for urothelial cancer. This will normally include a flexible cystoscopy, but many hospitals will differ in their choice of upper tract imaging as well as the use of other investigations such as urine cytology.
Aims and Objectives
Primary aims: Determine the prevalence of urological cancers in patients presenting to secondary care with suspected urinary tract cancer (e.g. in patients presenting with haematuria to urology services).
Secondary aims: To determine the difference in diagnostic practice across hospitals and countries and assess if this has an impact on diagnostic yield Identify an optimal diagnostic strategy that can be personalised to the individual patient
For further information go to: http://www.bursturology.com/p/identifyoverview.html
Supported by The Urology Foundation